PATENT CLAIM ANALYSIS

Application Number: 16069049
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "225800"]

Abstract:
The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.

Claim (Index 19):
The method according to  claim 11 , wherein said ErbB2 dependent cancer is lung cancer, ovarian cancer, stomach cancer, bladder cancer, uterine cancer, pancreas cancer, liver cancer, kidney cancer, gastroeosophageal cancer, gastric cancer, colorectal cancer, female genital tract cancer, endometrial cancer, anal cancer, breast cancer or neurofibroma.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15768388', '13497924', '15023159', '14385808', '15768257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7322635771088547
- 35 USC 102 Novelty (BERT): 0.5219694352595522
- Combined Prediction Score: 0.7112341629239245
- Mean Citation Score: 268.27641
- Max Citation Score: 282.37735
- Similarity Product: 190.65660459425445

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test